ICD-9-CM Coordination and Maintenance (C&M) Committee Meeting, 8877-8878 [2012-3484]

Download as PDF 8877 Federal Register / Vol. 77, No. 31 / Wednesday, February 15, 2012 / Notices ESTIMATE OF ANNUALIZED BURDEN HOURS—Continued Number of responses per respondent Number of respondents Average burden per respondent (in hours) Respondent Citation Importer ............................................. 20 1 15/60 5 5 40 1 1 30/60 10/60 3 7 30 5 20 4 1 1 30/60 1 1 60 5 20 Importer ............................................. 71.51(b)(3) Dogs/cats: Record of sickness or deaths. 71.52(d) Turtle Importation Permits 71.53(d) Importer Registration— Nonhuman Primates. 71.53(e) Recordkeeping ................... 71.55 Dead bodies ........................... 71.56 (a)(2) African Rodents—Request for exemption. 71.56(a)(iii) Appeal ........................... 2 1 1 2 Total ........................................... ........................................................... 2,740,638 ........................ ........................ 227,330 Importer ............................................. Non-Human Primate Importer ........... Non-Human Primate Importer ........... Importers ........................................... Importer ............................................. Kimberly S. Lane, Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. 2012–2951 Filed 2–14–12; 8:45 am] BILLING CODE 4163–18–P Dated: February 8, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2012–3487 Filed 2–14–12; 8:45 am] Centers for Disease Control and Prevention BILLING CODE 4163–18–P World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP STAC or Advisory Committee), National Institute for Occupational Safety and Health (NIOSH) sroberts on DSK5SPTVN1PROD with NOTICES Correction This notice was published in the Federal Register on January 31, 2012, Volume 77, Number 20, pages 4820– 4821. The meeting times and public comment times should read as follows: Committee Public Meeting Times and Dates: (All times are Eastern Standard Time). 12 p.m.–5 p.m., February 15, 2012, and 8:30 a.m.–4:00 p.m., February 16, 2012. Public Comment Times and Dates: (All times are Eastern Standard Time.) 3:45 p.m.–4:45 p.m., on February 15, 2012, and 8:45 a.m.–10:45 a.m., on February 16, 2012. Contact Person for More Information: Paul J. Middendorf, Ph.D., Designated Federal Officer, NIOSH, CDC, 4676 Columbia Parkway, Mail Stop R–45, Cincinnati, Ohio 45226, Telephone: 1 (888) 982–4748; email: wtcstac@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee VerDate Mar<15>2010 17:09 Feb 14, 2012 Jkt 226001 management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis (ACET) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 8:30 a.m.–5:30 p.m., March 6, 2012. 8:30 a.m.–2:30 p.m., March 7, 2012. Place: CDC, Corporate Square, Building 8, 1st Floor Conference Room, Atlanta, Georgia 30333, telephone: (404) 639–8317. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people. Purpose: This council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters to be Discussed: Agenda items include the following topics: (1) Tuberculosis issues in special populations; (2) United PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 Total burden States-Mexico border activities update; (3) tuberculosis outbreaks in federal prisons update; (4) ACET Workgroups Activities Updates; and (5) other tuberculosis-related issues. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Margie Scott-Cseh, Centers for Disease Control and Prevention, 1600 Clifton Road NE., M/S E–07, Atlanta, Georgia 30333, telephone: (404) 639–8317. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: February 8, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012–3486 Filed 2–14–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention ICD–9–CM Coordination and Maintenance (C&M) Committee Meeting National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, announces the following meeting. Name: ICD–9–CM Coordination and Maintenance (C&M) Committee meeting. Time and Date: 9 a.m.–5:30 p.m., March 5, 2012. Place: Centers for Medicare and Medicaid Services (CMS) Auditorium, 7500 Security Boulevard, Baltimore, Maryland 21244. Status: Open to the public, limited only by the space available. The meeting E:\FR\FM\15FEN1.SGM 15FEN1 8878 Federal Register / Vol. 77, No. 31 / Wednesday, February 15, 2012 / Notices room accommodates approximately 240 people. Security Considerations: Due to increased security requirements CMS has instituted stringent procedures for entrance into the building by nongovernment employees. Attendees will need to present valid government-issued picture identification, and sign-in at the security desk upon entering the building. Attendees who wish to attend the ICD–9–CM C&M meeting on March 5, 2012, must submit their name and organization by February 27, 2012, for inclusion on the visitor list. This visitor list will be maintained at the front desk of the CMS building and used by the guards to admit visitors to the meeting. Participants who attended previous ICD–9–CM C&M meetings will no longer be automatically added to the visitor list. You must request inclusion of your name prior to each meeting you attend. Please register to attend the meeting on-line at: https://www.cms.hhs.gov/ apps/events/. Please contact Mady Hue (410–786– 4510 or Marilu.hue@cms.hhs.gov), for questions about the registration process. Purpose: The ICD–9–CM Coordination and Maintenance Committee is a public forum for the presentation of proposed modifications to the International Classification of Diseases, NinthRevision, Clinical Modification. Matters to be Discussed: Tentative agenda items include: March 5, 2012 ICD–9–CM Procedure Topics: Administration of Fidaxomicin Placement of Modeling Catheter in Endovascular Graft Procedure Injection or Infusion of Glucarpidase ICD–10 Updates: ICD–10 MS–DRG Update ICD–10 HAC Translation List Impact of ICD–10 MS–DRGs Implementation ICD–10–CM Diagnosis Topics: Atypical femoral fracture Choking ‘‘game’’ Cognitive sequelae of cerebrovascular disease Family history of SIDS sroberts on DSK5SPTVN1PROD with NOTICES Addenda Agenda items are subject to change as priorities dictate. Note: CMS and NCHS will no longer provide paper copies of handouts for the meeting. Electronic copies of all meeting materials will be posted on the CMS and NCHS Web sites prior to the meeting at https://www.cms.hhs.gov/ ICD9ProviderDiagnosticCodes/03_ meetings.asp#TopOfPage and https:// www.cdc.gov/nchs/icd/icd9cm_ maintenance.htm. VerDate Mar<15>2010 17:09 Feb 14, 2012 Jkt 226001 Contact Persons for Additional Information: Donna Pickett, Medical Systems Administrator, Classifications and Public Health Data Standards Staff, NCHS, 3311 Toledo Road, Room 2337, Hyattsville, Maryland 20782, email dfp4@cdc.gov, telephone 301–458–4434 (diagnosis); Mady Hue, Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security Boulevard, Baltimore, Maryland 21244, email marilu.hue@cms.hhs.gov, telephone 410–786–4510 (procedures). The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Dated: February 8, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012–3484 Filed 2–14–12; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) Correction This notice was published in the Federal Register on February 1, 2012, Volume 77, Number 21, Page 5026. The matters to be discussed and times should read as follows: Matters To Be Discussed: The agenda will include discussions on: meningococcal vaccine, hepatitis B vaccine, tetanus, diphtheria, and acellular pertussis (Tdap) vaccine, influenza, vaccine supply, 13-valent pneumococcal conjugate vaccine, and measles-mumps-rubella (MMR) vaccine. Recommendation vote is scheduled for Tdap vaccine. Time will be available for public comment. Agenda items are subject to change as priorities dictate. Times and Dates: 8 a.m.–5 p.m., February 22, 2012. 8 a.m.–12:30 p.m., February 23, 2012. The Meeting is Web cast live via the World Wide Web; for instructions and more information on ACIP please visit the ACIP Web site: https://www.cdc.gov/ vaccines/recs/acip/. Contact Person for More Information: Stephanie B. Thomas, National Center Frm 00078 Fmt 4703 Dated: February 8, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012–3481 Filed 2–14–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Submission for OMB Review; Comment Request DEPARTMENT OF HEALTH AND HUMAN SERVICES PO 00000 for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road NE., MS–A27, Atlanta, Georgia 30333, telephone: (404)639–8836; Email ACIP@CDC.GOV. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sfmt 4703 Title: Tracking of Participants in the Head Start Impact Study. OMB No.: 0970–0229. Description: The Administration for Children and Families (ACF) within the Department of Health and Human Services (HHS) will collect follow-up information from children and families in the Head Start Impact Study. In anticipation of conducting a future follow-up for the study, ACF will collect information necessary to identify respondents’ current location and follow-up with respondents in the future. The Head Start Impact Study is a longitudinal study involving 4,667 first time enrolled three- and four-year-old preschool children across 84 nationally representative grantee/delegate agencies. Participants have been randomly assigned to either a Head Start group or a control group. Data collection for the study began in fall of 2002 and has been extended through late spring 2008 to include the participants’ 3rd grade year. Tracking of the participants has continued every spring beginning in 2009 and ending in 2011. ACF will continue to examine outcomes for the sample through the spring of the participant’s 12th grade year. To maintain adequate sample size, telephone interviews will be conducted in order to update the respondent’s location and contact information. This information will be collected from E:\FR\FM\15FEN1.SGM 15FEN1

Agencies

[Federal Register Volume 77, Number 31 (Wednesday, February 15, 2012)]
[Notices]
[Pages 8877-8878]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-3484]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


ICD-9-CM Coordination and Maintenance (C&M) Committee Meeting

    National Center for Health Statistics (NCHS), Classifications and 
Public Health Data Standards Staff, announces the following meeting.
    Name: ICD-9-CM Coordination and Maintenance (C&M) Committee 
meeting.
    Time and Date: 9 a.m.-5:30 p.m., March 5, 2012.

    Place: Centers for Medicare and Medicaid Services (CMS) Auditorium, 
7500 Security Boulevard, Baltimore, Maryland 21244.
    Status: Open to the public, limited only by the space available. 
The meeting

[[Page 8878]]

room accommodates approximately 240 people.
    Security Considerations: Due to increased security requirements CMS 
has instituted stringent procedures for entrance into the building by 
non-government employees. Attendees will need to present valid 
government-issued picture identification, and sign-in at the security 
desk upon entering the building. Attendees who wish to attend the ICD-
9-CM C&M meeting on March 5, 2012, must submit their name and 
organization by February 27, 2012, for inclusion on the visitor list. 
This visitor list will be maintained at the front desk of the CMS 
building and used by the guards to admit visitors to the meeting.
    Participants who attended previous ICD-9-CM C&M meetings will no 
longer be automatically added to the visitor list. You must request 
inclusion of your name prior to each meeting you attend.
    Please register to attend the meeting on-line at: https://www.cms.hhs.gov/apps/events/.
    Please contact Mady Hue (410-786-4510 or Marilu.hue@cms.hhs.gov), 
for questions about the registration process.
    Purpose: The ICD-9-CM Coordination and Maintenance Committee is a 
public forum for the presentation of proposed modifications to the 
International Classification of Diseases, Ninth-Revision, Clinical 
Modification.
    Matters to be Discussed: Tentative agenda items include:
March 5, 2012
    ICD-9-CM Procedure Topics:

Administration of Fidaxomicin
Placement of Modeling Catheter in Endovascular Graft Procedure
Injection or Infusion of Glucarpidase

    ICD-10 Updates:

ICD-10 MS-DRG Update
ICD-10 HAC Translation List
Impact of ICD-10 MS-DRGs Implementation

    ICD-10-CM Diagnosis Topics:

Atypical femoral fracture
Choking ``game''
Cognitive sequelae of cerebrovascular disease
Family history of SIDS

Addenda

    Agenda items are subject to change as priorities dictate.

    Note: CMS and NCHS will no longer provide paper copies of 
handouts for the meeting. Electronic copies of all meeting materials 
will be posted on the CMS and NCHS Web sites prior to the meeting at 
https://www.cms.hhs.gov/ICD9ProviderDiagnosticCodes/03_meetings.asp#TopOfPage and https://www.cdc.gov/nchs/icd/icd9cm_maintenance.htm.

    Contact Persons for Additional Information: Donna Pickett, Medical 
Systems Administrator, Classifications and Public Health Data Standards 
Staff, NCHS, 3311 Toledo Road, Room 2337, Hyattsville, Maryland 20782, 
email dfp4@cdc.gov, telephone 301-458-4434 (diagnosis); Mady Hue, 
Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security 
Boulevard, Baltimore, Maryland 21244, email marilu.hue@cms.hhs.gov, 
telephone 410-786-4510 (procedures).
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and the Agency 
for Toxic Substances and Disease Registry.

    Dated: February 8, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-3484 Filed 2-14-12; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.